Waldencast Acquisition Corp Total Liabilities
Waldencast Acquisition Corp total liabilities. Based on the latest financial reports, Waldencast Acquisition Corp (WALDW) has total liabilities worth $316.10 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check WALDW cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Waldencast Acquisition Corp (2020–2025)
Total liabilities of Waldencast Acquisition Corp from 2020 to 2025. This chart illustrates how Waldencast Acquisition Corp's total liabilities have evolved over time, based on quarterly financial data.
Waldencast Acquisition Corp Competitors by Total Liabilities
The table below lists competitors of Waldencast Acquisition Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Clene Inc
NASDAQ:CLNNW
|
USA | $34.67 Million |
|
Jasmine International Public Company Limited
F:JASN
|
Germany | €7.08 Billion |
|
Lexaria Bioscience Corp
NASDAQ:LEXXW
|
USA | $1.53 Million |
|
Aquis Exchange PLC
LSE:AQX
|
UK | GBX7.47 Million |
|
BriaCell Therapeutics Corp
NASDAQ:BCTXW
|
USA | $3.35 Million |
|
Ucommune International Ltd
NASDAQ:UKOMW
|
USA | $173.94 Million |
|
immatics biotechnologies GmbH
NASDAQ:IMTXW
|
USA | $105.09 Million |
|
Neovacs S.A.
PA:ALNEV
|
France | €4.10 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Waldencast Acquisition Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see WALDW asset base.
Liquidity & Leverage Metrics
Waldencast Acquisition Corp Total Liabilities Ratios Explained
Waldencast Acquisition Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Waldencast Acquisition Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Waldencast Acquisition Corp (2020–2025)
The table below shows the annual total liabilities of Waldencast Acquisition Corp from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $316.10 Million | +28.54% |
| 2024-12-31 | $245.92 Million | -10.06% |
| 2023-12-31 | $273.44 Million | -5.77% |
| 2022-12-31 | $290.18 Million | +99.64% |
| 2021-12-31 | $145.35 Million | +81673.68% |
| 2020-12-31 | $177.74K | -- |
About Waldencast Acquisition Corp
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; co… Read more